15 results
In accordance with its mandate to provide guidance to Member States on health policy matters, WHO publishes vaccine position papers providing global vaccine and immunization recommendations for...
The WHO website provides a list of certain diseases for which vaccines are available, and a list of some pathogens for which vaccines and/or monoclonal antibodies (mAbs) are in development. For each...
The Consortium aims to deliver a more sustainable, efficent, and transparent approach to generating disease burden and vaccine impact estimates. It works on aggregating the estimates across a...
Cette note de synthèse actualisée sur les
vaccins contre l’encéphalite japonaise (EJ)
remplace la note de 2006 résumant la position de l’OMS sur le même sujet; elle
renferme...
More than 300 million people who live in rural areas of the Mekong region are among the most at-risk for Japanese encephalitis (JE) infection due to changes in the Mekong region’s ecological...
Introduction: Two types of Japanese encephalitis (JE) vaccines, inactivated JE vaccine (JE-I) and live-attenuated JE vaccine (JE-L), are available and used in China. In particular, one JE-L, produced...
Background
The performance of live attenuated Japanese Encephalitis SA 14-14-2 vaccine (CD-JEV) among children previously given inactivated mouse brain-derived JE vaccine (IMBV) is unknown. We...
• Determining the costs and requirements to finance a new JE vaccination program is the final, essential step in deciding to introduce JE vaccine into a national immunization program.
• Before...
• WHO recommends that JE-endemic countries conduct a one-time JE vaccination campaign in the primary target population and then incorporate JE vaccine into the national immunization program (NIP)...
• Three JE vaccines have been prequalified by WHO as safe, effective, and acceptable for
procurement by United Nations agencies. • Vaccination programs using any of the WHO-prequalified JE...
• Cost-effectiveness analysis is a useful way to compare the costs and benefits of introducing and maintaining JE vaccination with those of not introducing the vaccine. It is an important tool for...
Japanese encephalitis (JE), a viral infection that causes a type of “brain fever,” is transmitted to
humans by mosquitoes. Because these mosquitoes usually live in areas with standing...
To facilitate introduction of live attenuated SA 14-14-2 Japanese encephalitis vaccine (LJEV) into the National Immunization Programme of Sri Lanka, we evaluated the safety and immunogenicity of...
This article presents the World Health Organizations (WHO) recommendations on the use of Japanese Encephalitis (JE) vaccines excerpted from the WHO position paper on Japanese Encephalitis vaccines...
Three types of JE vaccine are used in national immunization programs. Inactivated mouse brain–derived JE vaccine has been available for >50 years, but has a multidose primary and booster schedule...